NAIROBI, Jan. 10 (Xinhua) -- Kenya's Ministry of Health said on Saturday that it has approved the rollout of lenacapavir, a twice-yearly HIV prevention drug, for use in the East African country.
The ministry said the recommendation follows a comprehensive scientific assessment of the quality, safety, and efficacy of lenacapavir, conducted in line with Kenyan law and applicable international regulatory standards.
